Fortunato Morabito

Fortunato Morabito

UNVERIFIED PROFILE

Are you Fortunato Morabito?   Register this Author

Register author
Fortunato Morabito

Fortunato Morabito

Publications by authors named "Fortunato Morabito"

Are you Fortunato Morabito?   Register this Author

100Publications

3384Reads

38Profile Views

An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma.

Expert Opin Pharmacother 2020 Jan 18;21(1):29-38. Epub 2019 Nov 18.

Hematology and Oncology Department, Biotechnology Research Unit, Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2019.1689959DOI Listing
January 2020

Lenalidomide for the treatment of mantle cell lymphoma.

Expert Opin Pharmacother 2019 Apr 4;20(5):487-494. Epub 2019 Jan 4.

b Biotechnology Research Unit, AO , Cosenza , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2018.1561865DOI Listing
April 2019

Venetoclax for the treatment of chronic lymphocytic leukemia.

Expert Opin Investig Drugs 2017 Nov 9;26(11):1307-1316. Epub 2017 Oct 9.

b Department of Hemato-Oncology , Unità di Ricerca Biotecnologica (URB) , Aprigliano , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1386173DOI Listing
November 2017

Autologous Stem Cell Transplantation in Patients With Multiple Myeloma: An Activity-based Costing Analysis, Comparing a Total Inpatient Model Versus an Early Discharge Model.

Clin Lymphoma Myeloma Leuk 2017 08 6;17(8):506-512. Epub 2017 Jun 6.

Hematology Unit, Azienda Ospedaliera Cosenza, Cosenza, Italy; Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano (CS), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.05.018DOI Listing
August 2017

Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase.

Am J Hematol 2017 Jun 24;92(6):E91-E93. Epub 2017 Mar 24.

Institute of Haematology and Oncology, Hospital Clínic University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24707DOI Listing
June 2017

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.

Am J Hematol 2017 Apr 13;92(4):375-380. Epub 2017 Feb 13.

Department of Hematology, Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24660DOI Listing
April 2017

Pomalidomide in multiple myeloma.

Expert Opin Pharmacother 2017 02 26;18(2):133-137. Epub 2016 Dec 26.

a Dipartimento di Onco-Ematologia , Unità Operativa di Ematologia Azienda Ospedaliera di Cosenza , Cosenza , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2016.1274973DOI Listing
February 2017

Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia.

Br J Haematol 2016 12 5;175(5):983-985. Epub 2016 Jan 5.

Haematology-Oncology Department, Azienda Ospedaliera Cosenza, Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13907DOI Listing
December 2016

The role of tandem stem cell transplantation for multiple myeloma patients.

Expert Opin Biol Ther 2016 6;16(4):515-34. Epub 2016 Feb 6.

b Biotechnology Research Unit , Azienda Sanitaria Provinciale di Cosenza , Aprigliano (CS) , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2016.1136285DOI Listing
October 2016

Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation.

Leuk Lymphoma 2016 10 15;57(10):2445-7. Epub 2016 Feb 15.

a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1140163DOI Listing
October 2016

Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target.

Leuk Lymphoma 2015 7;56(12):3250-6. Epub 2015 Jul 7.

c Hadassah University Hospital and Hebrew University Medical School , Jerusalem , Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1061193DOI Listing
September 2016

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review.

J Immunol Res 2015 16;2015:968212. Epub 2015 Dec 16.

Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, 87051 Aprigliano, Italy; Hematology Unit, Azienda Ospedaliera di Cosenza, 87100 Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/968212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695673PMC
September 2016

Panobinostat for the treatment of acute myelogenous leukemia.

Expert Opin Investig Drugs 2016 Sep 8;25(9):1117-31. Epub 2016 Aug 8.

e Department of Clinical and Experimental Medicine, Hematology Division , University of Pisa , Pisa , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2016.1216971DOI Listing
September 2016

Sorafenib for the treatment of multiple myeloma.

Expert Opin Investig Drugs 2016 Jun 6;25(6):743-9. Epub 2016 Apr 6.

a Hematology Unit , Azienda Ospedaliera di Cosenza , Cosenza , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2016.1169272DOI Listing
June 2016

Ixazomib for the treatment of multiple myeloma.

Expert Opin Investig Drugs 2015 3;24(9):1287-98. Epub 2015 Jul 3.

Dipartimento Oncoematologico, Unità Operativa Complessa di Ematologia, Azienda Ospedaliera di Cosenza , Viale della Repubblica, 87100 Cosenza , Italy +39 0984 681329 ; +39 0984 681866 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2015.1065250DOI Listing
April 2016

Bendamustine in multiple myeloma.

Eur J Haematol 2015 Nov 14;95(5):377-88. Epub 2015 Jul 14.

Haematology Unit, Department of Onco-Haematology, A.O. of Cosenza, Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12609DOI Listing
November 2015

Promising therapies for the treatment of chronic lymphocytic leukemia.

Expert Opin Investig Drugs 2015 Jun 1;24(6):795-807. Epub 2015 Mar 1.

Azienda Ospedaliera di Cosenza, Dipartimento Oncoematologico, Unità Operativa Complessa di Ematologia , Viale della Repubblica, Cosenza 87100 , Italy +39 0984 681329 ; +39 0984 681866 ; ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2015.1021920DOI Listing
June 2015

Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.

Biol Blood Marrow Transplant 2015 May 27;21(5):881-8. Epub 2015 Jan 27.

Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano (CS), Italy; Haematology Unit, Azienda Ospedaliera Cosenza, Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.01.021DOI Listing
May 2015

Smoldering multiple myeloma: to treat or not to treat.

Expert Opin Pharmacother 2015 Apr 8;16(6):785-90. Epub 2015 Feb 8.

Unità Operativa di Ematologia Azienda Ospedaliera di Cosenza , Cosenza , Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1007952DOI Listing
April 2015

Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.

Expert Opin Biol Ther 2015 Feb 29;15(2):149-54. Epub 2014 Nov 29.

Hematology and Stem Cell Transplant Unit, Azienda Ospedaliera BMM , Via Melacrino n.1, 89100 Reggio Calabria , Italy +39 0965 393804 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2015.988611DOI Listing
February 2015

Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.

Expert Rev Hematol 2014 Oct 31;7(5):691-5. Epub 2014 Aug 31.

Department of Oncology-Hematology, Azienda Ospedaliera Pugliese-Ciaccio Hospital Center, Viale Pio X, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.954542DOI Listing
October 2014

A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).

Int J Hematol 2014 Sep 27;100(3):290-5. Epub 2014 Jul 27.

Department of Oncology-Hematology, Pugliese-Ciaccio Hospital Center, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-014-1634-7DOI Listing
September 2014

Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.

Genes Chromosomes Cancer 2014 Jul 4;53(7):612-21. Epub 2014 Apr 4.

Department of Clinical Sciences and Community Health, Center of Molecular and Genetic Epidemiology, University of Milan, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.22171
Publisher Site
http://dx.doi.org/10.1002/gcc.22171DOI Listing
July 2014

Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patients.

Expert Opin Pharmacother 2014 Jul 12;15(10):1315-20. Epub 2014 May 12.

Azienda Ospedaliera di Cosenza, Unità Operativa Complessa di Ematologia, Dipartimento Oncoematologico , Viale della Repubblica, 87100 Cosenza , Italy +39 0 984 681329 ; +39 0984 791751 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.919257DOI Listing
July 2014

Erythroid but not cytogenetic response in a case with 5q- syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?

Leuk Lymphoma 2014 Jun 9;55(6):1408-9. Epub 2013 Sep 9.

Unità Operativa Complessa di Ematologia, Dipartimento Oncoematologico, Azienda Ospedaliera di Cosenza , Cosenza , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.834053DOI Listing
June 2014

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

J Clin Oncol 2014 Mar 21;32(7):634-40. Epub 2014 Jan 21.

Antonio Palumbo, Sara Bringhen, Alessandra Larocca, Valeria Magarotto, Paola Omedé, Roberto Mina, Mario Boccadoro, and Giulia Benevolo, Azienda Ospedaliera (A.O.) Città della Salute e della Scienza di Torino; Daniela Gottardi, A.O. Ordine Mauriziano; Roberto Passera, San Giovanni Battista Hospital, University of Torino, Torino; Davide Rossi and Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara; Francesco Di Raimondo, Ferrarotto Hospital, University of Catania, Catania; Francesca Patriarca, A.O. Universitaria, Udine; Anna Levi and Maria Teresa Petrucci, Sapienza University of Rome; Luca Franceschini, Tor Vergata University Hospital, Rome; Iolanda Donatella Vincelli, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria; Mariella Grasso, S. Croce e Carle Hospital, Cuneo; Renato Zambello, Università degli Studi di Padova, Padova; Vittorio Montefusco, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori Milano, University of Milano, Milan; Antonietta Pia Falcone, IRCCS Casa Sollievo della Sofferenza and Unità di Ematologia, San Giovanni Rotondo; Roberto Marasca, University of Modena, Modena; Fortunato Morabito, A.O. di Cosenza, Cosenza; Tommasina Guglielmelli, "S. Luigi Gonzaga" Hospital, Orbassano; Chiara Nozzoli, A.O. Universitaria Careggi, Firenze; Massimo Offidani, Ospedali Riuniti, Ancona; Roberto Ria, University of Bari "Aldo Moro" Medical School, Bari; Pellegrino Musto, IRCCS-Centro Regionale Oncologico Basilicata, Rionero in Vulture; and Michele Cavo, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.0023DOI Listing
March 2014

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

Clin Cancer Res 2013 Nov 13;19(21):5890-900. Epub 2013 Sep 13.

Authors' Affiliations: Department of Onco-Hematology, A.O. of Cosenza, Cosenza; Department of Clinical Sciences and Community Health, University of Milano and Hematology 1 CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano; SS Molecular Diagnostics, Scientific Direction, and Direzione Scientifica, IRCCS, San Martino IST, Genoa; Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara; Division of Hematology, A.O. Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia; Division of Hematology, University of Messina, Messina; Department of Oncology and Hematology, Pugliese-Ciaccio Hospital; University of Magna Graecia and Cancer Center, Catanzaro; Division of Hematology, Department of Biomedical Sciences, University of Catania and Ferrarotto Hospital, Catania; and Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0622DOI Listing
November 2013

An old drug with a new future: bendamustine in multiple myeloma.

Expert Opin Pharmacother 2013 Nov 21;14(16):2263-80. Epub 2013 Sep 21.

Unitá Operativa Complessa di Ematologia, Dipartimento Oncoematologico, Azienda Ospedaliera di Cosenza , Viale della Repubblica, 87100 Cosenza , Italy +39 0 984 681329 ; +39 0 984 791751 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2013.837885DOI Listing
November 2013

Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical need.

Expert Rev Hematol 2013 Aug;6(4):441-9

Dipartimento Onco-Ematologico Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2013.814845DOI Listing
August 2013

Perspectives in the treatment of multiple myeloma.

Expert Opin Biol Ther 2013 Jun 22;13 Suppl 1:S1-22. Epub 2013 May 22.

Unità Operativa Complessa di Ematologia, Dipartimento Oncoematologico, Azienda Ospedaliera di Cosenza, Viale della Repubblica, 87100 Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.799132DOI Listing
June 2013

Oxidative stress in oncohematologic diseases: an update.

Expert Rev Hematol 2013 Jun;6(3):317-25

Department of Clinical & Experimental Medicine, School & Unit of Allergy and Clinical Immunology, University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.13.21DOI Listing
June 2013

Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium.

Curr Cancer Drug Targets 2012 Sep;12(7):743-56

Unità Operativa Complessa di Ematologia, Dipartimento Oncoematologico, Azienda Ospedaliera di Cosenza, Viale della Repubblica, 87100 Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156800912802429373DOI Listing
September 2012

Emerging biological insights and novel treatment strategies in multiple myeloma.

Expert Opin Emerg Drugs 2012 Sep;17(3):407-38

Unità Operativa Complessa di Ematologia, Dipartimento Oncoematologico, Azienda Ospedaliera di Cosenza, Viale della Repubblica, 87100 Cosenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.2012.713345DOI Listing
September 2012

Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?

Expert Opin Biol Ther 2012 May 24;12(5):609-21. Epub 2012 Mar 24.

Oncology Department, Haematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Bianchi-Melacrino-Morelli, 89100 Reggio, Calabria, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2012.674937DOI Listing
May 2012